About OS Therapies
OS Therapies is a private company based in Grasonville, Maryland. It has reported $4,059,000 raised in five offerings on Form D since December 2019. Its chief executive is Paul Romness.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 8, 2023 | Dec 14, 2023 | $700,000of $2.0M target | 3 | $233K | Unsecured Convertible Promissory Note and Restricted Stock Grant for shares of Class A Common Stock.Rule 506(b) | Form D ↗ |
| Nov 16, 2022 | Jan 11, 2023 | $2,000,000fully sold | 11 | $181K | Equity, Options, Convertible promissory notes including underlying Class A common stock issuable upon conversion of such notes.Rule 506(b) | Form D ↗ |
| Jul 15, 2021 | Sep 1, 2021 | $1,000,000of $5.0M target | 1 | $1.0M | DebtRule 506(b) | Form D ↗ |
| Not yet | May 1, 2020 | $0of $5.0M target | 0 | — | Debt, Convertible DebtRule 506(b) | Form D ↗ |
| Jul 25, 2018 | Dec 5, 2019 | $359,000of $500K target | 11 | $32,636 | Convertible debtRule 506(b) | Form D ↗ |
| Total, five offerings | $4,059,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on OS Therapies's Form D filed Dec 14, 2023.
PR
Paul Romness
Founder, President, Chief Executive Officer and Director
CG
Colin Goddard
Chairman of the Board
TS
Theodore Search
Director
JB
Joacim Borg
Director
CA
Christopher Acevedo
Chief Financial Officer
RP
Robert Petit
Chief Medical Officer and Chief Scientific Officer
JC
John Ciccio
Director
Earlier filings also listed Jutta Wanner (chief technology officer, last listed Jan 2023).